Lyka Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve 1. To consider and approve the Unaudited ....
LYKALABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lyka Labs has notified the stock exchanges that its Board of Directors will meet on Wednesday, 12th November 2025. The key agenda is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the second quarter and six months ended 30th September 2025, along with the Limited Review Report from the Statutory Auditor. Additionally, the Board will consider a proposal to shift the company's Registered Office from Gujarat to Maharashtra and approve the notice for an Extra-Ordinary General Meeting (EGM) to seek shareholder approval for the same. The filing is a routine regulatory disclosure under SEBI Listing Regulations.
This is a routine compliance intimation with no immediate impact on the stock. Investors should watch the Q2/H1 FY26 results announcement on 12th November for actual performance, while the registered office shift and EGM are administrative items requiring shareholder approval.